Trevi Therapeutics (TRVI) Stock Price & Financial Analysis
Trevi Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Trevi Therapeutics
What is the current stock price for TRVI?
As of the latest trading session, TRVI stock trades at $11.94. The 52-week range is $4.85–$14.39, with a day range of $11.27–$12.28.
What is the P/E ratio for TRVI?
The P/E ratio (Price-to-Earnings) for TRVI is shown in the Key Statistics section. This valuation metric helps compare Trevi Therapeutics, Inc. to industry peers.
Does TRVI pay dividends?
Trevi Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TRVI?
Based on 5 analysts, the consensus for TRVI is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of TRVI?
Trevi Therapeutics's market capitalization is $1.73B, classifying it as a small-cap company. Trevi Therapeutics operates in the Healthcare sector within the Biotechnology industry.